New Y-Maze Test May Be Useful Measure of Memory and Thinking Skills
A new behavioral test called the free-movement pattern Y-maze could be useful in assessing problems with working memory, both in…
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A new behavioral test called the free-movement pattern Y-maze could be useful in assessing problems with working memory, both in…
Remote coaching via telehealth could help people with Parkinson’s disease stay physically active, even when in-person events aren’t feasible,…
Inhaled bacterial toxins can cause inflammation in a brain region associated with smell, and this inflammation may help in the…
People who had a concussion are more likely to be diagnosed later in life with Parkinson’s disease and other…
Regular use of aspirin or ibuprofen could lower the risk of Parkinson’s disease associated with mutations in…
Loss of the sense of smell is associated with longer disease duration in Parkinson’s, suggesting this sense increasingly fails…
People with Parkinson’s disease who use passive coping strategies, rather than active ones, are more likely to experience worse depression,…
A multi-faceted intervention that included staff education, electronic alerts, and requiring new reports, improved the timeliness with which Parkinson’s disease patients…
The first participant has been dosed in a Phase 1 clinical trial evaluating the safety of PTC857, PTC Therapeutics‘…
A planned Phase 2 clinical trial evaluating ANVS401, Annovis Bio‘s lead investigational therapy for people in the early stages of …
Get regular updates to your inbox.